Abstract
This study investigates the influence of exosomes secreted by chemoresistant ovarian cancer (OC) cells on angiogenesis. Exosomes were isolated from sensitive (SKOV3) and cisplatin-resistant (SKOV3-DDP) OC cells and co-cultured with Human Umbilical Vein Endothelial Cells (HUVECs). Results demonstrate that both SKOV3-exo and SKOV3-DDP-exo are internalized by endothelial cells, promoting proliferation, migration, invasion, and tube formation. Notably, SKOV3-DDP-exo exhibited significantly higher angiogenic potency. Molecular analysis revealed that miR-130a is highly enriched in chemoresistant OC cells and their secreted exosomes, identifying it as a primary driver of the observed pro-angiogenic phenotype in the tumor microenvironment.
Introduction
Ovarian cancer (OC) remains a leading cause of gynecologic cancer-related deaths, primarily due to the high rate of recurrence and the development of cisplatin resistance. Recent research has shifted focus from intrinsic cellular resistance to the role of the tumor microenvironment (TME). Angiogenesis, the formation of new blood vessels, is a hallmark of tumor progression and is often enhanced in drug-resistant tumors. Exosomes, small extracellular vesicles (30–150 nm), serve as critical mediators of intercellular communication by transporting proteins and RNAs. This study explores how exosomes from chemoresistant OC cells "reprogram" endothelial cells to support tumor vascularization.
Methods and Characterization
The study utilized three primary cell models: sensitive SKOV3 cells, cisplatin-resistant SKOV3-DDP cells, and normal ovarian epithelial IOSE80 cells as a control. Exosomes were isolated from cell culture supernatants via ultracentrifugation and characterized to ensure purity and identity.
Transmission Electron Microscopy (TEM) revealed typical cup-shaped morphology, while Nanoparticle Tracking Analysis (NTA) confirmed a size distribution consistent with exosomes, predominantly between 50 and 150 nm.
Further validation was performed using Western Blotting, which confirmed the presence of established exosomal markers, including HSP70, CD9, and CD63, across all isolated samples, confirming the successful isolation of exosomes.
Functional Impact on Endothelial Cells
To assess the functional role of these vesicles, isolated exosomes were labeled with PKH26 and co-cultured with HUVECs. Confocal microscopy confirmed that HUVECs actively internalize the exosomes. Functional assays demonstrated that treatment with SKOV3-DDP-exo led to a significant increase in HUVEC proliferation ($p < 0.001$) compared to controls.
Furthermore, scratch wound and Transwell assays showed that exosomes from resistant cells significantly enhanced endothelial cell migration and invasion. In Matrigel tube formation assays, HUVECs treated with SKOV3-DDP-exo formed more complex and robust capillary-like structures than those treated with sensitive SKOV3-exo, suggesting that resistant cells secrete a more potent angiogenic cargo.
miR-130a as a Key Angiogenic Driver
Quantitative real-time PCR (qRT-PCR) was employed to identify the molecular components responsible for this increased potency. The researchers found that miR-130a was significantly upregulated in SKOV3-DDP cells compared to sensitive SKOV3 cells. Crucially, this high expression was mirrored in the secreted exosomes. The enrichment of miR-130a in SKOV3-DDP-exo suggests it is a major signaling molecule used by chemoresistant cells to manipulate the TME and promote vascular growth.
Conclusion
This study highlights a novel mechanism by which chemoresistant ovarian cancer cells promote tumor progression. By secreting exosomes enriched with miR-130a, these cells actively stimulate angiogenesis in the surrounding microenvironment. These findings suggest that exosomal miR-130a could serve as both a biomarker for drug resistance and a potential therapeutic target to inhibit tumor vascularization in resistant ovarian cancer.
Summary updated